Latin Post
Friday March 29, 2024
US
Politics
Entertainment
World
Economy
Health
Lifestyle
FDA Panel OKs First COVID Pill 'Molnupiravir' From Merck
FDA panel "narrowly' backs Merck's COVID pill known as molnupiravir.
Pfizer's COVID Pill Cuts 89 Percent of Severe COVID Cases: Clinical Trial Results
Nov 05, 2021 09:57 PM EDT
By Mary Webber
U.S. pharmaceutical company Pfizer has developed a COVID pill noting that it reduces the risk of severe COVID cases by 89 percent, according to the clinical trials of the company.
Most Read
Brazil Supreme Court Summons Jair Bolsonaro To Answer Why He Stayed at Hungarian Embassy During Investigations; May Face Evading Arrest Charges
Donald Trump's Truth Social Stock Bubble Will Inevitably Burst, Warn Experts
Donald Trump Viciously Mocked for Selling 'Trump Bible' While Having Money Problems
Donald Judd Foundation Files Lawsuit Against Kim Kardashian Over Misattributed Tables in 2022 Video
Utah Mom Who Poisoned Husband with Fentanyl, Faces New Fraud Charges and Attempted Murder
Don't Miss It
Donald Trump's Truth Social Stock Bubble Will Inevitably Burst, Warn Experts
Illinois Stabbing Suspect Faces 11 Counts of Murder, Attempted Murder Charges After Rampage that Kills 4, Injures 7